Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)

[1]  C. Mel Wilcox,et al.  Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia , 1996, Digestive Diseases and Sciences.

[2]  S. Shapiro,et al.  NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease , 2000, Cancer Causes & Control.

[3]  L. G. García Rodríguez,et al.  Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.

[4]  G. Fürstenberger,et al.  Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. , 2001, Carcinogenesis.

[5]  L. G. García Rodríguez,et al.  Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study. , 2000, Epidemiology.

[6]  J. Weissfeld,et al.  Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. , 2000, The New England journal of medicine.

[7]  B. Rump,et al.  Long-Term Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Colorectal Adenomas , 2000, Digestion.

[8]  J. Baron,et al.  Nonsteroidal anti-inflammatory drugs and cancer prevention. , 2000, Annual review of medicine.

[9]  N. Arber,et al.  Nonsteroidal anti-inflammatory drugs and prevention of colorectal cancer , 1999, Current gastroenterology reports.

[10]  W. Ray,et al.  Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. , 1999, Archives of internal medicine.

[11]  J. Zhang,et al.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.

[12]  J. Woosley,et al.  Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. , 1998, Gastroenterology.

[13]  Y. Yazaki,et al.  Effects of sulindac on sporadic colorectal adenomatous polyps. , 1997, Gut.

[14]  A. Schatzkin,et al.  The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  J. Weissfeld,et al.  The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  I. Sartori.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals. , 1996 .

[17]  D. Forman,et al.  Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence. , 1996, Scandinavian journal of gastroenterology. Supplement.

[18]  B. Levin,et al.  Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  K. Schmid,et al.  Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment , 1995, Diseases of the colon and rectum.

[20]  G. Morgan.  Nonsteroidal antiinflammatory drugs and colorectal cancer , 1995, Cancer.

[21]  P. Lavori,et al.  Effect of sulindac on sporadic colonic polyps. , 1995, Gastroenterology.

[22]  P. Dolara,et al.  Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. , 1994, Gastroenterology.

[23]  C. Williams,et al.  Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis , 1993, The British journal of surgery.

[24]  R. Sampliner,et al.  NSAID effect on sporadic colon polyps. , 1993, The American journal of gastroenterology.

[25]  N. Petrelli,et al.  Aspirin use, cancer, and polyps of the large bowel , 1993, Cancer.

[26]  J. Manson,et al.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial. , 1993, Journal of the National Cancer Institute.

[27]  J D Hardcastle,et al.  Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. , 1993, BMJ.

[28]  J. Baron,et al.  Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. , 1993, Journal of the National Cancer Institute.

[29]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[30]  J. Travers,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1992, The New England journal of medicine.

[31]  J. Bordas,et al.  Effects of long-term sulindac therapy on colonic polyposis. , 1991, Annals of internal medicine.

[32]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[33]  S. Shapiro,et al.  A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.

[34]  E. Cerise,et al.  Sulindac for polyposis of the colon. , 1989, American journal of surgery.

[35]  J. Salomon,et al.  Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. , 1979, Journal of the National Cancer Institute.

[36]  J. Salomon,et al.  Mechanism of inhibition of tumour growth by aspirin and indomethacin. , 1978, British Journal of Cancer.

[37]  V. Hial,et al.  Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. , 1976, European journal of pharmacology.

[38]  J. Humes,et al.  Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in balb/c mice , 1975, International journal of cancer.